RELAPSED PEDIATRIC ALL
Clinical trials for RELAPSED PEDIATRIC ALL explained in plain language.
Never miss a new study
Get alerted when new RELAPSED PEDIATRIC ALL trials appear
Sign up with your email to follow new studies for RELAPSED PEDIATRIC ALL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for kids with tough leukemia: transplant + CAR t combo trial launches
Disease control Recruiting nowThis study tests a new way to do a stem cell transplant for children with a hard-to-treat type of leukemia (CD19+ ALL). It uses a special type of immune cell (CAR T cells) after a transplant from a partially matched family donor. The goal is to see if this combination is safe and…
Matched conditions: RELAPSED PEDIATRIC ALL
Phase: PHASE1 • Sponsor: St. Jude Children's Research Hospital • Aim: Disease control
Last updated May 22, 2026 13:52 UTC
-
New CAR T-Cell trial offers hope for Tough-to-Treat blood cancers
Disease control Recruiting nowThis study tests a personalized treatment using a patient's own immune cells, modified to attack cancer. It is for people with relapsed aggressive lymphoma or acute lymphoblastic leukemia (ALL) who have not responded to standard therapies. The approach aims to control the disease…
Matched conditions: RELAPSED PEDIATRIC ALL
Phase: PHASE1, PHASE2 • Sponsor: University of Alberta • Aim: Disease control
Last updated May 19, 2026 12:01 UTC